165 related articles for article (PubMed ID: 19348657)
1. Clinical usefulness of a supplementary cyclosporin administration with a topical application of maxacalcitol ointment for patients with moderate psoriasis vulgaris.
Abe M; Syuto T; Hasegawa M; Yokoyama Y; Ishikawa O
J Dermatol; 2009 Apr; 36(4):197-201. PubMed ID: 19348657
[TBL] [Abstract][Full Text] [Related]
2. Clinical usefulness and patient satisfaction for treatment with low-dose cyclosporin administration in patients with moderate psoriasis vulgaris.
Abe M; Ishibuchi H; Syuto T; Sogabe Y; Yokoyama Y; Ishikawa O
J Dermatol; 2007 May; 34(5):290-3. PubMed ID: 17408436
[TBL] [Abstract][Full Text] [Related]
3. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator.
Barker JN; Ashton RE; Marks R; Harris RI; Berth-Jones J
Br J Dermatol; 1999 Aug; 141(2):274-8. PubMed ID: 10468799
[TBL] [Abstract][Full Text] [Related]
4. Effects of maxacalcitol ointment on skin lesions in patients with psoriasis receiving treatment with adalimumab.
Karakawa M; Komine M; Kishimoto M; Maki N; Matsumoto A; Sugai J; Ohtsuki M
J Dermatol; 2016 Nov; 43(11):1354-1357. PubMed ID: 27450634
[TBL] [Abstract][Full Text] [Related]
5. Calcipotriol ointment versus cream in psoriasis vulgaris.
Duweb G; Aldebani S; Elzorghany A; Benghazil M; Alhaddar J
Int J Clin Pharmacol Res; 2003; 23(2-3):47-51. PubMed ID: 15018018
[TBL] [Abstract][Full Text] [Related]
6. Calcitriol ointment and clobetasol propionate cream: a new regimen for the treatment of plaque psoriasis.
Lahfa M; Mrowietz U; Koenig M; Simon JC
Eur J Dermatol; 2003; 13(3):261-5. PubMed ID: 12804986
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of calcipotriol and maxacalcitol in combination with narrow-band ultraviolet B therapy for the treatment of psoriasis vulgaris.
Noborio R; Kobayashi K; Shintani Y; Morita A
Photodermatol Photoimmunol Photomed; 2006 Oct; 22(5):262-4. PubMed ID: 16948829
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of high-concentration tacalcitol ointment in psoriasis vulgaris after changing from other high-concentration vitamin D3 ointments.
Syuto T; Ishibuchi H; Sogabe Y; Yokoyama Y; Ishikawa O
Dermatol Online J; 2008 Feb; 14(2):2. PubMed ID: 18700105
[TBL] [Abstract][Full Text] [Related]
9. Combined topical calcipotriene ointment 0.005% and various systemic therapies in the treatment of plaque-type psoriasis vulgaris: review of the literature and results of a survey sent to 100 dermatologists.
Katz HI
J Am Acad Dermatol; 1997 Sep; 37(3 Pt 2):S62-8. PubMed ID: 9344188
[TBL] [Abstract][Full Text] [Related]
10. Topical calcipotriol (MC 903) for psoriasis: a clinical study.
Mozzanica N; Cattaneo A; Schmitt E; Legori A; Finzi AF
Acta Derm Venereol Suppl (Stockh); 1994; 186():169-70. PubMed ID: 8073826
[TBL] [Abstract][Full Text] [Related]
11. Calcipotriol improves the efficacy of cyclosporine in the treatment of psoriasis vulgaris.
Kokelj F; Torsello P; Plozzer C
J Eur Acad Dermatol Venereol; 1998 Mar; 10(2):143-6. PubMed ID: 9553911
[TBL] [Abstract][Full Text] [Related]
12. Spotlight on calcipotriene/betamethasone dipropionate in psoriasis vulgaris of the trunk, limbs, and scalp.
McCormack PL
Am J Clin Dermatol; 2011 Dec; 12(6):421-4. PubMed ID: 21967117
[TBL] [Abstract][Full Text] [Related]
13. Treatment of psoriasis vulgaris with topical vitamin D analogue (calcipotriol): open multicenter study.
Kullavanijaya P; Gritiyarangsan P; Huiprasert P; Leenutaphong V
J Med Assoc Thai; 1999 Oct; 82(10):974-7. PubMed ID: 10561958
[TBL] [Abstract][Full Text] [Related]
14. Topical calcipotriene ointment and etretinate: another combination therapy for psoriasis vulgaris.
Vázquez-López F; Pérez-Oliva N; Hernandez-Mejia R
J Am Acad Dermatol; 1997 May; 36(5 Pt 1):803. PubMed ID: 9146555
[No Abstract] [Full Text] [Related]
15. Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris.
Lebwohl MG
Cutis; 2007 Jan; 79(1 Suppl 2):3-4. PubMed ID: 17367039
[No Abstract] [Full Text] [Related]
16. Nail psoriasis: combined therapy with systemic cyclosporin and topical calcipotriol.
Feliciani C; Zampetti A; Forleo P; Cerritelli L; Amerio P; Proietto G; Tulli A; Amerio P
J Cutan Med Surg; 2004; 8(2):122-5. PubMed ID: 15129317
[TBL] [Abstract][Full Text] [Related]
17. A comparison of twice-daily calcipotriol ointment with once-daily short-contact dithranol cream therapy: quality-of-life outcomes of a randomized controlled trial of supervised treatment of psoriasis in a day-care setting.
de Korte J; van der Valk PG; Sprangers MA; Damstra RJ; Kunkeler AC; Lijnen RL; Oranje AP; de Rie MA; de Waard-van der Spek FB; Hol CW; van de Kerkhof PC
Br J Dermatol; 2008 Feb; 158(2):375-81. PubMed ID: 18067483
[TBL] [Abstract][Full Text] [Related]
18. Topical combination therapy with vitamin D3 and corticosteroid ointment for palmoplantar pustulosis: A prospective, randomized, left-right comparison study.
Muro M; Kawakami H; Matsumoto Y; Abe N; Tsuboi R; Okubo Y
J Dermatolog Treat; 2016; 27(1):51-3. PubMed ID: 26108445
[TBL] [Abstract][Full Text] [Related]
19. Topical calcipotriene 0.005% and betamethasone dipropionate 0.064% maintains efficacy of etanercept after step-down dose in patients with moderate-to-severe plaque psoriasis: results of an open label trial.
Kircik LH
J Drugs Dermatol; 2011 Aug; 10(8):878-82. PubMed ID: 21818509
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of topical calcipotriol in psoriasis].
Welsh-Lozano O; Gómez-de Garza M; Jaramillo-Moreńo G; González-González SE; Morales-Monsiváis MA
Gac Med Mex; 1996; 132(5):471-4. PubMed ID: 9011512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
